Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study


By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 7, Iss. 1, 2017-05 ,pp. : 136-142

Karger

Access to resources Recommend Favorite

An Economic Evaluation of Donepezil in Mild to Moderate Alzheimer’s Disease: Results of a 1-Year, Double-Blind, Randomized Trial

By  

Dementia and Geriatric Cognitive Disorders, Vol. 15, Iss. 1, 2002-12 ,pp. : 44-54

Karger

Access to resources Recommend Favorite

A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer's Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 5, Iss. 3, 2015-09 ,pp. : 361-374

Karger

Access to resources Recommend Favorite

Cerebrolysin in Mild-to-Moderate Alzheimer's Disease: A Meta-Analysis of Randomized Controlled Clinical Trials

By  

Dementia and Geriatric Cognitive Disorders, Vol. 39, Iss. 5-6, 2015-03 ,pp. : 332-347

Karger

Access to resources Recommend Favorite

Comprehensive, Individualized, Person-Centered Management of Community-Residing Persons with Moderate-to-Severe Alzheimer Disease: A Randomized Controlled Trial

By  

Dementia and Geriatric Cognitive Disorders, Vol. 43, Iss. 1-2, 2017-01 ,pp. : 100-117

Karger

Access to resources Recommend Favorite